Researcher overcomes radiation resistance in leukemia with an engineered precision medicine

Improved survival rates demonstrated in mouse models of aggressive human leukemia using leukemia cells taken directly from patients, according to new EBioMedicine study IMAGE: CD19L-sTRAIL selectively binds to the CD19 receptor on leukemia cells via its CD19L moiety upon which its sTRAIL component kills the cells by engaging the TRAIL death receptors.

http://ift.tt/1NcXhLd